Trilogy Capital »

Vertex Pharmaceuticals Incorporated shares owned by Trilogy Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Trilogy Capital from 13F filings

Historical chart of Trilogy Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Trilogy Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Trilogy Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7M 3.6k 465.04
2024-06-30 $1.3M 2.9k 468.67
2024-03-31 $429k 1.0k 417.88
2018-09-30 $6.0k 33 181.82
2018-06-30 $6.0k 33 181.82
2018-03-31 $5.0k 33 151.52

More positions owned by Trilogy Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Msci Usa Mmentm (MTUM)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
First Tr Value Line Divid In SHS (FVD)
Thor Finl Technologies Tr Equal Weight Low (THLV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Wisdomtree Tr Intl Qulty Div (IQDG)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Wisdomtree Tr Yield Enhancd Us (AGGY)

View all positions for Trilogy Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated